These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6492549)
1. [Effect of rifampicin on cell mediated immunity in patients with pulmonary tuberculosis--with special reference to interferon-producing ability of peripheral blood lymphocytes]. Hirano A Kekkaku; 1984 Jun; 59(6):385-93. PubMed ID: 6492549 [No Abstract] [Full Text] [Related]
2. Immunity in pulmonary tuberculosis and effect of therapy. Narang NK; Jindal BK J Assoc Physicians India; 1990 Jun; 38(6):442-3. PubMed ID: 2384466 [No Abstract] [Full Text] [Related]
3. [Experimental study of the effect of rifampicin on antituberculosis immunity]. Chernushenko EF; Shiniberov VA Probl Tuberk; 1983 Feb; (2):47-51. PubMed ID: 6601802 [No Abstract] [Full Text] [Related]
4. [Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis]. Chernushenko EF; Kogosova LS; Il'nitskiĭ IG; Petrashenko AI; Goncharova SI Probl Tuberk; 1989; (7):39-43. PubMed ID: 2798385 [TBL] [Abstract][Full Text] [Related]
5. Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients. Galal SH; Khalil SH; el Husseiny W; Brock J Allerg Immunol (Leipz); 1988; 34(4):249-54. PubMed ID: 3147590 [TBL] [Abstract][Full Text] [Related]
6. Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts. Humber DP; Nsanzumuhire H; Aluoch JA; Webster AD; Aber VR; Mitchison DA; Girling DJ; Nunn AJ Am Rev Respir Dis; 1980 Sep; 122(3):425-36. PubMed ID: 7416618 [No Abstract] [Full Text] [Related]
7. [Immunological status of newly detected patients with destructive pulmonary tuberculosis]. Khomenko AG; Averbakh MM; Rudoĭ NM; Litvinov VI; Gergert VIa Probl Tuberk; 1979 Apr; (4):13-7. PubMed ID: 312495 [No Abstract] [Full Text] [Related]
8. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies. Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136 [TBL] [Abstract][Full Text] [Related]
9. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus]. Karachunskiĭ MA; Gergert VIa; Iakovleva OB Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939 [TBL] [Abstract][Full Text] [Related]
10. [Effect of vitamins on spontaneous in vitro rosette formation by the lymphocytes of pulmonary tuberculosis patients]. Volosevich GV Probl Tuberk; 1980 Jun; (6):64-6. PubMed ID: 6967212 [No Abstract] [Full Text] [Related]
11. Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis. Immanuel C; Swamy R; Kannapiran M; Vijayalakshmi S; Sundaram V; Jagannath K; Paramasivan CN Int J Tuberc Lung Dis; 1997 Apr; 1(2):175-80. PubMed ID: 9441084 [TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte blast transformation reaction indices in the clinical picture of tuberculosis and their interrelationship with tuberculin tests and the synthesis of specific antibodies]. Knoring BE; Chuzhova NM Probl Tuberk; 1979 Apr; (4):31-7. PubMed ID: 441052 [No Abstract] [Full Text] [Related]
13. Rifampin and cell-mediated immune responses in tuberculosis. Goldstein RA; Ang UH; Foellmer JW; Janicki BW Am Rev Respir Dis; 1976 Feb; 113(2):197-202. PubMed ID: 1247234 [TBL] [Abstract][Full Text] [Related]